Pilar de la Huerta Martinez (Sygnis Pharma AG)

de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia)

	Organisation	Sygnis Pharma AG
	Today	Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)
	Group	2invest (Group)
	Former/major organisation	Genetrix S.L.
	Today	Expedeon Biotech S.L.U.
	Group	2invest (Group)
	Product	BIOTECH
	Product 2	Qualiphi® DNA polymerase

Record changed: 2022-04-24

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Pilar de la Huerta Martinez

[1] Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg....
[2] Sygnis AG. (4/24/17). "Press Release: Sygnis AG Expands Access to Chinese Market with Second OEM Deal with Tanon". Madrid & Heidelberg....
[3] Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg....
[4] Sygnis AG. (3/1/17). "Press Release: Sygnis AG Announces Management Changes. David Roth Appointed Chief Financial Officer (CFO) ". Madrid & Heidelberg....
[5] Sygnis AG. (2/2/17). "Press Release: Sygnis AG Announces the Launch of TrueHelix". Madrid & Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)